RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,381,249 | -17.8% | 383,950 | -7.5% | 0.00% | -50.0% |
| Q2 2023 | $7,764,894 | +13.0% | 415,235 | +10.9% | 0.00% | +100.0% |
| Q1 2023 | $6,871,066 | -26.2% | 374,445 | -20.3% | 0.00% | -50.0% |
| Q4 2022 | $9,306,396 | -26.7% | 470,020 | -11.0% | 0.00% | -33.3% |
| Q3 2022 | $12,704,000 | +70.8% | 527,997 | +29.6% | 0.00% | +50.0% |
| Q2 2022 | $7,436,000 | +296.0% | 407,489 | +377.1% | 0.00% | – |
| Q1 2022 | $1,878,000 | +170.6% | 85,418 | +351.9% | 0.00% | – |
| Q4 2021 | $694,000 | -44.0% | 18,900 | -52.7% | 0.00% | – |
| Q3 2021 | $1,240,000 | -85.8% | 39,923 | -85.5% | 0.00% | -100.0% |
| Q2 2021 | $8,724,000 | +253.6% | 274,400 | +147.0% | 0.00% | – |
| Q1 2021 | $2,467,000 | +11.9% | 111,100 | -0.4% | 0.00% | – |
| Q4 2020 | $2,204,000 | – | 111,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |